GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (MEX:AXNX) » Definitions » Additional Paid-In Capital

Axonics (MEX:AXNX) Additional Paid-In Capital : MXN17,319 Mil(As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Axonics Additional Paid-In Capital?


Axonics's quarterly additional paid-in capital declined from Sep. 2023 (MXN17,803 Mil) to Dec. 2023 (MXN17,548 Mil) but then stayed the same from Dec. 2023 (MXN17,548 Mil) to Mar. 2024 (MXN17,319 Mil).

Axonics's annual additional paid-in capital increased from Dec. 2021 (MXN16,484 Mil) to Dec. 2022 (MXN18,902 Mil) but then declined from Dec. 2022 (MXN18,902 Mil) to Dec. 2023 (MXN17,548 Mil).


Axonics Additional Paid-In Capital Historical Data

The historical data trend for Axonics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Additional Paid-In Capital Chart

Axonics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 6,846.41 10,389.51 16,484.21 18,902.25 17,547.60

Axonics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,703.96 17,310.26 17,803.02 17,547.60 17,319.47

Axonics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Axonics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Axonics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Axonics (MEX:AXNX) Business Description

Traded in Other Exchanges
Address
26 Technology Drive, Irvine, CA, USA, 92618
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.